EUVIMEDEUVIMED entdecken
Crossref

Associations between radioactive iodine treatment for hyperthyroidism and cancer incidence and mortality

Harry D Momo iD, Megan R Haymart iD, Xu Shi iD, Alison M Mondul iD

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgag058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Harry D Momo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Hyperthyroidism, Neoplasms, Radiation-Induced, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Cancer Institute of the National Institutes of Health, University of Michigan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Radioactive iodine (RAI) has been one of the main treatments for hyperthyroidism since the 1940s, but its long-term safety, particularly regarding cancer risk, remains controversial. This study evaluated associations between RAI treatment and cancer incidence and mortality, including overall and site-specific cancers.

Methods

We conducted a retrospective cohort study utilizing a University of Michigan de-identified electronic health record dataset. Adults (aged ≥18 years) newly diagnosed with hyperthyroidism between 2006 and 2019, without prior cancer, and treated with RAI, antithyroid medications, or thyroidectomy were included. Participants were followed until cancer diagnosis, death, or December 2022. Time-dependent Cox models estimated hazard ratios (HRs) and 95% CIs comparing RAI with other therapies using age-adjusted (age-adj) and multivariable (mv) models adjusting for demographics, lifestyle and clinical covariates. Sensitivity analysis stratified by cohort entry period, follow-up duration and restriction to ≥2 years of follow-up.

Results

The cohort included 6435 participants contributing 52 909 person-years (mean follow up 8.2 years; range 0.5-17 years), with 487 incident cancers and 157 cancer deaths. RAI treatment was not associated with overall cancer incidence (mv HR = 1.02 [0.76-1.47], P = .734) or cancer mortality (mv HR = 0.81 [0.45-1.44], P = .471). However, RAI was significantly associated with increased breast cancer risk among women (mv HR = 2.24 [1.21-4.17], P = .011), and among postmenopausal women (mv HR = 2.65 [1.24-5.66], P = .011). An elevated pancreatic cancer mortality was observed in those with ≥2 years of follow-up (age-adj HR = 4.05 [1.01-16.20], P = .042).

Conclusion

RAI treatment was associated with increased breast cancer incidence but not overall cancer incidence or mortality. Findings for pancreatic cancer mortality were suggestive. These results support the importance of long-term safety monitoring among RAI-treated patients

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iodine RadioisotopesHyperthyroidismNeoplasms, Radiation-InducedNeoplasmsHumansFemaleIncidenceMiddle AgedRetrospective StudiesAdultMaleAgedFollow-Up StudiesThyroidectomy

Stichwörter der Autor:innen

cancer incidencehyperthyroidismlong-termradioactive iodinesafety

Substanzen

Iodine Radioisotopes

Autor:innen und Institutionen

  • Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.
  • Department of Internal Medicine, Division of Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI 48109, USA.
  • Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA.

ORCID-Profile: Harry D Momo, Megan R Haymart, Xu Shi, Alison M Mondul

Förderung

  • National Cancer Institute of the National Institutes of Health
  • University of Michigan

Zitieren

APA

Momo, H. D., Haymart, M. R., Shi, X., & Mondul, A. M. (2026). Associations between radioactive iodine treatment for hyperthyroidism and cancer incidence and mortality. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag058

Vancouver

Momo HD, Haymart MR, Shi X, Mondul AM. Associations between radioactive iodine treatment for hyperthyroidism and cancer incidence and mortality. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag058

BibTeX
@article{Momo2026,
  author = {Momo, Harry D and Haymart, Megan R and Shi, Xu and Mondul, Alison M},
  title = {Associations between radioactive iodine treatment for hyperthyroidism and cancer incidence and mortality},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgag058}
}
Kostenlos starten →